Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1987-02-26
1990-08-28
Moskowitz, Margaret
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
435 7, 4351723, 435320, 530350, 536 27, A61K 3902, C12N 1500, C07G 700
Patent
active
049523953
ABSTRACT:
Recombinant 540 amino acid residue and 517 amino acid residue proteins encoded by the genome of Mycobacterium tuberculosis are disclosed as are vectors for propagating their DNA sequences and expressing the proteins. Also disclosed are methods for using those proteins. Peptides that correspond substantially to the sequences of those proteins and methods of their use are also disclosed, as are polymers containing 517 protein pentapeptides as repeating units.
REFERENCES:
patent: 3853833 (1974-12-01), Li
patent: 4431187 (1984-02-01), Rumble et al.
patent: 4489158 (1984-12-01), Strauss
patent: 4575484 (1986-03-01), Strauss
patent: 4689397 (1987-08-01), Shinnick et al.
patent: 4703008 (1987-10-01), Lin
patent: 4724144 (1988-02-01), Rook et al.
Shinnick et al., "The Etiologic Agents of Leprosy and Tuberculosis Show an Immunoreactive Protein Antigen with the Vaccui Strain Mycobacterium bovis BCG", Infect-Immunity, vol. 55, No. 8, Aug. 1987, pp. 1932-1935.
Kingston et al., "Immunological Activity of a 14-Kilo-dalton Recombinant Protein of Mycobacterium tuberculosis H37Ru", Infect. Immun., vol. 55, No. 12, Dec. 1987, pp. 3149-3154.
Mustafa et al., Lepr. Rev. 57, Suppl. 2:123-130 (1986).
Kaufmann et al., Eur. J. Immun., 17:351-357 (Mar. 1987).
Lu et al., Infect. Immun., 55:2378-2382 (Oct. 1987).
Melancon-Kaplan et al., Proc. Natl. Acad. Sci. U.S.A., 85:1917-1921 (1988).
Boom et al., Infect. Immun., 55:2223-2229 (Sep. 1987).
Oftung et al., J. Immunol., 141:2749-2754 (1988).
Emmrich et al. (1986), J. Exp. Med., 163:1024-1029.
Gillis et al. (1985), Infect. Immun., 49:371-377.
Engers et al. (1985), Infect. Immun., 48:603-605.
Engers et al. (1986), Infect. Immun., 51:718-720.
Gillis et al. (1982), Infect. Immun., 37:172-178.
Mehra et al. (1986), Proc. Natl. Acad. Sci. U.S.A., 83:7013-7017.
Young et al. (1985), Nature, 316:450-452.
Mustafa et al. (1986), Nature, 319:63-66.
Thole et al. (1985), Infect. Immun., 50:800-806; and Young et al. (1985), Proc. Natl. Acad. Sci., U.S.A., 82:2583-2587.
Houghten Richard
Shinnick Thomas
Mohamed Abdel A.
Moskowitz Margaret
Scripps Clinic and Research Foundation
LandOfFree
Mycobacterial recombinants and peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycobacterial recombinants and peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycobacterial recombinants and peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1588731